Inogen Inc (INGN)
9.21
-0.25
(-2.64%)
USD |
NASDAQ |
Nov 21, 16:00
9.22
+0.01
(+0.11%)
After-Hours: 20:00
Inogen Revenue (Quarterly): 88.83M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 88.83M |
| June 30, 2024 | 88.76M |
| March 31, 2024 | 78.02M |
| December 31, 2023 | 75.90M |
| September 30, 2023 | 83.97M |
| June 30, 2023 | 83.64M |
| March 31, 2023 | 72.16M |
| December 31, 2022 | 88.09M |
| September 30, 2022 | 105.39M |
| June 30, 2022 | 103.38M |
| March 31, 2022 | 80.38M |
| December 31, 2021 | 76.40M |
| September 30, 2021 | 93.10M |
| June 30, 2021 | 101.56M |
| March 31, 2021 | 86.93M |
| December 31, 2020 | 73.98M |
| September 30, 2020 | 74.33M |
| June 30, 2020 | 71.69M |
| March 31, 2020 | 88.49M |
| December 31, 2019 | 78.92M |
| September 30, 2019 | 91.76M |
| June 30, 2019 | 101.06M |
| March 31, 2019 | 90.20M |
| December 31, 2018 | 86.53M |
| Date | Value |
|---|---|
| September 30, 2018 | 95.29M |
| June 30, 2018 | 97.24M |
| March 31, 2018 | 79.05M |
| December 31, 2017 | 63.79M |
| September 30, 2017 | 69.03M |
| June 30, 2017 | 64.12M |
| March 31, 2017 | 52.50M |
| December 31, 2016 | 50.85M |
| September 30, 2016 | 54.42M |
| June 30, 2016 | 54.57M |
| March 31, 2016 | 42.99M |
| December 31, 2015 | 40.45M |
| September 30, 2015 | 40.78M |
| June 30, 2015 | 44.03M |
| March 31, 2015 | 33.75M |
| December 31, 2014 | 29.12M |
| September 30, 2014 | 29.39M |
| June 30, 2014 | 30.39M |
| March 31, 2014 | 23.63M |
| December 31, 2013 | 19.76M |
| September 30, 2013 | 19.78M |
| June 30, 2013 | 20.16M |
| March 31, 2013 | 15.75M |
| December 31, 2012 | 13.84M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
71.69M
Minimum
Jun 2020
105.39M
Maximum
Sep 2022
84.70M
Average
83.80M
Median
Revenue (Quarterly) Benchmarks
| Boston Scientific Corp | 4.209B |
| ResMed Inc | 1.225B |
| NovaBay Pharmaceuticals Inc | 2.441M |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.963M |
| Total Expenses (Quarterly) | 96.63M |
| EPS Diluted (Quarterly) | -0.25 |
| Enterprise Value | 98.70M |
| Gross Profit Margin (Quarterly) | 46.54% |
| Profit Margin (Quarterly) | -6.71% |
| Earnings Yield | -24.43% |
| Normalized Earnings Yield | -24.43 |